Based on the hypothesis that early changes in T cells in patients with unresectable or metastatic GC treated with cytotoxic chemotherapy may be associated with durable response and prognosis, this study aimed to investigate the relationships among T cells, clinical factors, and prognosis, focusing on circulating PD-1+CD8+ T cells. This evidence concerns the gene CD8A and gastric cancer.